Abbott Laboratories
His appointment comes ahead of the med tech startup's clinical trials for its continuous molecular monitoring device.
Bigfoot has agreed to develop and commercialize new programs that will integrate with Abbott's diabetes management platform.
The company's executives lauded the CGM system, which saw a 72.9% increase in organic sales during the last quarter, and hinted at implementations of the tech beyond diabetes alone.